This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lüdemann, J. Articles by Döcke, W.-D. Search for Related Content PubMed Articles by Lüdemann, J. Articles by Döcke, W.-D. Social Bookmarking                         What's this?

Leukocyte/Endothelium Activation and Interactions During Femoral Percutaneous Transluminal Angioplasty

Department of Internal Medicine, Ev. Hospital Königin Elisabeth Herzberge; Institute of Medical Immunology, Humboldt University/Charité, Berlin, Germany

Karl-Ludwig Schulte, MD

Department of Internal Medicine, Ev. Hospital Königin Elisabeth Herzberge, Herzbergstr. 79, 10362 Berlin, Germany

Oliver Hader, MD

Stefan Brehme, MD

Department of Internal Medicine, Ev. Hospital Königin Elisabeth Herzberge, Berlin, Germany

Hans-Dieter Volk, MD

Wolf-Dietrich Döcke, MD

Institute of Medical Immunology, Humboldt University/Charité, Berlin, Germany

Recent data suggest that leukocyte-endothelium activation/interactions are important for restenosis after percutaneous transluminal angioplasty (PTA). Ten patients with superficial femoral artery occlusive disease (stage Fontaine llb) were examined after a percutaneous transluminal angioplasty (PTA) versus a preceding aortoangiography (AAG). Blood samples from corresponding femoral arteries and veins were obtained before, immediately after, and 4 hours after each procedure. The authors examined the ex vivo respiratory burst and leukocytic expression of adhesion molecules flowcytometrically, adhesion molecule plasma concentrations, and inflammatory mediators concentrations in plasma and in endotoxin-stimulated whole blood cultures by ELISA, and the leukocyte counts.

After PTA, venous plasma concentrations of soluble (s)L-selectin (148.2 ± 14.7%, p<0.05 vs 100% baseline ± sem), sP-selectin (130.7 ±6.9%, p<0.01; sE-selectin (117.5 ±8.3%, p<0.05 vs arterial), sLFA-3 (130.7 ±15.8%, p<0.05) were increased. Expressions of L-selectin (93.0 ±5.7%, p<0.05 vs arterial), CD11a (98.8 ±3.8%, p=0.06), CD18 (96.9 ±4.0%, p<0.05 vs arterial), and ICAM-1 (89.1 ±7.7%, p<0.05) on polymorphonuclear neutrophils (PMN), and arteriovenous leukocyte counts (arterial: 103.5 ±5.4%, venous: 91.1 ±3.3%, p<0.05) decreased. Venous ex vivo secretions of oxygen radicals (141.4 ±28.1%, p<0.05 vs AAG), PMN-elastase (173.7 ±35.7%, p<0.05 vs AAG), and interleukin (IL)-8 (226.5 ±56.4%, p<0.001; p<0.0001 vs AAG), as well as PMN-elastase (173.7 ±35.7%, p<0.05 vs AAG) and tumor necrosis factor (TNF)-alpha plasma concentrations (124.1 ±11.9%, p=0.06) rose. Four hours after PTA, a leukocytosis and exhausted TNF-alpha (69.8 ±10.4%, p< 0.05) and IL-8 secretions (72.4 ±4.6%, p<0.01) occurred.

PTA induced local leukocyte-endothelium activations (stronger ex vivo mediator productions) and interactions (decreased venous leukocyte counts, increased plasma concentrations, and decreased leukocytic expression of adhesion molecules) with the release of inflammatory mediators (higher plasma concentrations and exhaustions after 4 hours).

Vascular and Endovascular Surgery, Vol. 35, No. 4, 293-301 (2001)
DOI: 10.1177/153857440103500409


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?